COMPASS Pathways Operating Expenses 2019-2024 | CMPS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

COMPASS Pathways operating expenses from 2019 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

COMPASS Pathways operating expenses from 2019 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
Elevance Health (ELV)	$93.4B
Cencora (COR)	$48.3B
DiDi Global (DIDIY)	$22.2B
Natera (NTRA)	$22.1B
ICON (ICLR)	$17.7B
Viatris (VTRS)	$16B
Avantor (AVTR)	$14.1B
Revvity (RVTY)	$13.6B
CochLear (CHEOY)	$12.8B
Solventum (SOLV)	$12.2B
BioMerieux (BMXMF)	$11.9B
Medpace Holdings (MEDP)	$10.5B
Charles River Laboratories (CRL)	$10B
HealthEquity (HQY)	$9.1B
Doximity (DOCS)	$9B
Sonic Healthcare (SKHHY)	$8.9B
Bausch + Lomb (BLCO)	$6.9B
Life Times (LTH)	$5.1B
Organon (OGN)	$3.9B
Sotera Health (SHC)	$3.6B
BrightSpring Health Services (BTSG)	$3.3B
Surgery Partners (SGRY)	$2.9B
Concentras Parent (CON)	$2.8B
PACS (PACS)	$2.5B
Alignment Healthcare (ALHC)	$2.3B
Ardent Health Partners (ARDT)	$2.3B
Premier (PINC)	$2.2B
GeneDx Holdings (WGS)	$2.2B
Ryman Healthcare (RYHTY)	$2B
GoodRx Holdings (GDRX)	$1.9B